Direxion Daily Travel & Vacation Bull 2X Shares (ARCA: OOTO)

Latest News for Direxion Daily Travel & Vacation Bull 2X Shares (ARCA:OOTO)

Long Ideas

Short Ideas

Technicals

Travel

Trading Ideas

ETFs

General

ABNB

OOTO

Direxion Daily Travel &amp;Vacation Bull 2X Shares (NYSE: OOTO) was edging about 4% higher on Friday after soaring over 14% between March 24 and Thursday.

Looking To Trade Disney, Delta And Other Travel, Vacation Stocks Bullishly? This ETF Offers 2X Leverage

Direxion Daily Travel & Vacation Bull 2X Shares

OOTOYA HLDGS CO LTD by OOTOYA HLDGS CO LTD

OOTOYA Holdings Co Ltd

News

Dividends

NDAQ

Nasdaq Increases Quarterly Dividend From $0.22 To $0.24

Laboratory Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>) reported quarterly earnings of $3.68 per share which beat the analyst consensus estimate of $3.48 by 5.75 percent. This is a 6.36 percent increase over earnings of $3.46 per share from the same period last year. The company reported quarterly sales of $3.177 billion which beat the analyst consensus estimate of $3.117 billion by 1.93 percent. This is a 4.58 percent increase over sales of $3.038 billion the same period last year.

Earnings

Earnings Beats

Laboratory Corporation Of America Holdings

Laboratory Corp Q1 2024 Adj EPS $3.68 Beats $3.48 Estimate, Sales $3.177B Beat $3.117B Estimate

Ultralife (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULBI#NASDAQ">ULBI</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.10 by 110 percent. The company reported quarterly sales of $41.927 million which beat the analyst consensus estimate of $38.000 million by 10.33 percent. This is a 31.37 percent increase over sales of $31.916 million the same period last year.

ULBI

Ultralife Q1 2024 Adj EPS $0.21 Beats $0.10 Estimate, Sales $41.927M Beat $38.000M Estimate

Biotech

Large Cap

Guidance

Health Care

Bristol Myers Squibb Revises 2024 Adjusted EPS Guidance From $7.10-$7.40 To $0.40-$0.70 Versus Consensus Of $0.66, Reflecting The Impact Of Recent Transactions

Baird analyst Mark Marcon maintains ASGN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASGN#NYSE">ASGN</a>) with a Neutral and raises the price target from $99 to $104.

Price Target

Analyst Ratings

ASGN

Baird Maintains Neutral on ASGN, Raises Price Target to $104

DTE Energy Reaffirms FY24 Operating EPS Of $6.54-$6.83 Vs. $6.69 Est.

Newmont Sees FY24 Attributable Gold Production Of 6,930Koz

LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 20 percent decrease over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $4.98 million which missed the analyst consensus estimate of $13.51 million by 63.15 percent. This is a 35.87 percent decrease over sales of $7.76 million the same period last year.

Earnings Misses

LVWR

LiveWire Gr Q1 EPS $(0.12) Beats $(0.14) Estimate, Sales $4.98M Miss $13.51M Estimate

Keurig Dr Pepper Reaffirmed FY24 Guidance For Constant Currency Net Sales Growth In Mid-Single-Digit Range And Adjusted Diluted EPS Growth In High-Single-Digit Range

Garrett Motion Reiterates 2024 Outlook With Net Sales Of $3.80B-$3.95B; Est $3.899B

Ardagh Metal Packaging (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMBP#NYSE">AMBP</a>) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of undefined by Infinity percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.141 billion which missed the analyst consensus estimate of $1.149 billion by 0.72 percent. This is a 0.88 percent increase over sales of $1.131 billion the same period last year.

AMBP

Ardagh Metal Packaging Q1 2024 Adj EPS $0.01 Beats undefined Estimate, Sales $1.141B Miss $1.149B Estimate

Approximately&nbsp;$190 million&nbsp;to&nbsp;$240 million&nbsp;is associated with marine maintenance capital and improvements to existing inland and coastal marine equipment, including the remaining ballast water treatment systems on some coastal vessels, and facility improvements. Approximately&nbsp;$90 million&nbsp;is associated with growth capital spending in both our businesses.

Kirby Corporation Expects To Generate Net Cash Provided From Operating Activities Of $600M-$700M In 2024; Capital Spending Is Expected To Range Between $290M-$330M

Bristol Myers Squibb Says It Is Executing Strategic Productivity Initiative To Deliver ~$1.5B In Cost Savings, The Majority Of Which Will Be Reinvested To Fund Innovation And Drive Growth

&quot;We are pleased with our first quarter results, which reflect improvement in adjusted EBITDA and adjusted EPS, driven by disciplined execution across our key priorities,&quot; said Cindy J. Miller, President and Chief Executive Officer. &quot;We remain on track to achieve our full-year 2024 guidance and long-term outlook.&quot;

SRCL

Stericycle CEO Says "We remain on track to achieve our full-year 2024 guidance and long-term outlook."

Baird analyst David Manthey maintains Watsco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSO#NYSE">WSO</a>) with a Outperform and raises the price target from $420 to $460.

Baird Maintains Outperform on Watsco, Raises Price Target to $460

Nasdaq Sees FY24 Non-GAAP Operating Expense $2.125B-$2.185B

Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) reported quarterly earnings of $0.55 per share which beat the analyst consensus estimate of $0.36 by 52.78 percent. The company reported quarterly sales of $4.023 billion which beat the analyst consensus estimate of $3.670 billion by 9.62 percent. This is a 50.17 percent increase over sales of $2.679 billion the same period last year.

Newmont Q1 2024 Adj EPS $0.55 Beats $0.36 Estimate, Sales $4.023B Beat $3.670B Estimate

Expro Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPRO#NYSE">XPRO</a>) reported quarterly earnings of $0.09 per share which missed the analyst consensus estimate of $0.12 by 25 percent. This is a 800 percent increase over earnings of $0.01 per share from the same period last year. The company reported quarterly sales of $383.489 million which beat the analyst consensus estimate of $369.621 million by 3.75 percent. This is a 13.03 percent increase over sales of $339.279 million the same period last year.

XPRO

Expro Gr Hldgs Q1 2024 Adj EPS $0.09 Misses $0.12 Estimate, Sales $383.489M Beat $369.621M Estimate

Bristol-Myers Squibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) reported quarterly losses of $(4.40) per share which beat the analyst consensus estimate of $(4.44) by 0.9 percent. This is a 314.63 percent decrease over earnings of $2.05 per share from the same period last year. The company reported quarterly sales of $11.865 billion which beat the analyst consensus estimate of $11.458 billion by 3.56 percent. This is a 4.66 percent increase over sales of $11.337 billion the same period last year.

Bristol-Myers Squibb Q1 2024 Adj EPS $(4.40) Beats $(4.44) Estimate, Sales $11.865B Beat $11.458B Estimate

Stericycle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCL#NASDAQ">SRCL</a>) reported quarterly earnings of $0.57 per share which met the analyst consensus estimate. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $664.900 million which missed the analyst consensus estimate of $679.277 million by 2.12 percent. This is a 2.84 percent decrease over sales of $684.300 million the same period last year.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Direxion Daily Travel & Vacation Bull 2X Shares (ARCA:OOTO)

Friday, March 31, 2023